The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...

Viking Therapeutics shared on Sunday the latest data of its two clinical trials testing an injection and pill versions ...

Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for ...

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. But Amgen stock dipped a fraction in late trades.

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Loss Becomes is now streaming their new single "Broken Mirrors" featuring the powerful vocals of Killswitch Engage frontman Jesse Leach. The single features a music video by Sean Ageman and riffs ...

Researchers found that weight loss occurred in all diets, and there were no significant differences long term. Remember, don’t drastically reduce the number of calories you eat daily.